Cargando…
Outpatient Therapies for COVID-19: How Do We Choose?
BACKGROUND: Several outpatient coronavirus disease 2019 (COVID-19) therapies have reduced hospitalization in randomized controlled trials. The choice of therapy may depend on drug efficacy, toxicity, pricing, availability, and available infrastructure. To facilitate comparative decision-making, we e...
Autores principales: | Lee, Todd C, Morris, Andrew M, Grover, Steven A, Murthy, Srinivas, McDonald, Emily G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807279/ https://www.ncbi.nlm.nih.gov/pubmed/35165657 http://dx.doi.org/10.1093/ofid/ofac008 |
Ejemplares similares
-
Willful: how we choose what we do
por: Robb, Richard
Publicado: (2019) -
Multiple Vaccines: How Do We Choose?
por: Minkoff, Neil B.
Publicado: (2007) -
Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020) -
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
por: Lofgren, Sarah M, et al.
Publicado: (2020) -
National survey of mentorship in Canadian general surgery residency programs: Where are we and what do we need?
por: Delisle, Megan, et al.
Publicado: (2017)